Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP903621.RANKnr_FzRxjYoz8kQkmPV9QO5y3M2BuFeL4pn3o24yA4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP903621.RANKnr_FzRxjYoz8kQkmPV9QO5y3M2BuFeL4pn3o24yA4130_assertion type Assertion NP903621.RANKnr_FzRxjYoz8kQkmPV9QO5y3M2BuFeL4pn3o24yA4130_head.
- NP903621.RANKnr_FzRxjYoz8kQkmPV9QO5y3M2BuFeL4pn3o24yA4130_assertion description "[This work suggests that multilevel inhibition of the PI3K/Akt/mTOR pathway and double-block of cell cycle progression are effective strategies for DLBCL therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP903621.RANKnr_FzRxjYoz8kQkmPV9QO5y3M2BuFeL4pn3o24yA4130_provenance.
- NP903621.RANKnr_FzRxjYoz8kQkmPV9QO5y3M2BuFeL4pn3o24yA4130_assertion evidence source_evidence_literature NP903621.RANKnr_FzRxjYoz8kQkmPV9QO5y3M2BuFeL4pn3o24yA4130_provenance.
- NP903621.RANKnr_FzRxjYoz8kQkmPV9QO5y3M2BuFeL4pn3o24yA4130_assertion SIO_000772 19223503 NP903621.RANKnr_FzRxjYoz8kQkmPV9QO5y3M2BuFeL4pn3o24yA4130_provenance.
- NP903621.RANKnr_FzRxjYoz8kQkmPV9QO5y3M2BuFeL4pn3o24yA4130_assertion wasDerivedFrom befree-20140225 NP903621.RANKnr_FzRxjYoz8kQkmPV9QO5y3M2BuFeL4pn3o24yA4130_provenance.
- NP903621.RANKnr_FzRxjYoz8kQkmPV9QO5y3M2BuFeL4pn3o24yA4130_assertion wasGeneratedBy ECO_0000203 NP903621.RANKnr_FzRxjYoz8kQkmPV9QO5y3M2BuFeL4pn3o24yA4130_provenance.